Response by Butt et al to Letter Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial"

被引：1
|
作者：
Butt, Jawad H. [1 ,2 ]
Solomon, Scott D. [3 ]
McMurray, John J. V. [1 ]
机构：
[1] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Scotland
[2] Copenhagen Univ Hosp Rigshospitalet, Dept Cardiol, Copenhagen, Denmark
[3] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA USA
来源：
CIRCULATION | 2023年 / 147卷 / 14期
关键词：
D O I：
10.1161/CIRCULATIONAHA.123.064052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1119 / 1120
页数：2
相关论文
共 50 条
  • [1] Letter by Wong and Demers Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial"
    Wong, Eric K. C.
    Demers, Catherine
    CIRCULATION, 2023, 147 (14) : 1118 - 1118
  • [2] Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial
    Butt, Jawad H.
    Jhund, Pardeep S.
    Belohlavek, Jan
    de Boer, Rudolf A.
    Chiang, Chern-En
    Desai, Akshai S.
    Drozdz, Jaroslaw
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Katova, Tzvetana
    Kitakaze, Masafumi
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Lindholm, Daniel
    Bachus, Erasmus
    Martinez, Felipe
    Merkely, Bela
    Petersson, Magnus
    Saraiva, Jose F. Kerr
    Shah, Sanjiv J.
    Vaduganathan, Muthiah
    Vardeny, Orly
    Wilderang, Ulrica
    Claggett, Brian C.
    Solomon, Scott D.
    McMurray, John J., V
    CIRCULATION, 2022, 146 (16) : 1210 - 1224
  • [3] Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial
    Kondo, Toru
    Jering, Karola S.
    Borleffs, C. Jan Willem
    de Boer, Rudolf A.
    Claggett, Brian L.
    Desai, Akshay S.
    Dobreanu, Dan
    Inzucchi, Silvio E.
    Hernandez, Adrian F.
    Janssens, Stefan P.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Petersson, Magnus
    Vinh, Pham Nguyen
    Vaduganathan, Muthiah
    Solomon, Scott D.
    McMurray, John J. V.
    CIRCULATION, 2023, 147 (14) : 1067 - 1078
  • [4] Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial
    Kondo, Toru
    Jering, K. S.
    De Boer, R. A.
    Claggett, B. L.
    Desai, A. S.
    Inzucchi, S. I.
    Hernandez, A. F.
    Jhund, P. S.
    Kosiborod, M. N.
    Lam, C. S. P.
    Langkilde, A. M.
    A Martinez, F.
    Vaduganathan, M.
    Solomon, S. D.
    Mcmurray, J. J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 199 - 199
  • [5] Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
    Orly Vardeny
    James C. Fang
    Akshay S. Desai
    Pardeep S. Jhund
    Brian Claggett
    Muthiah Vaduganathan
    Rudolf A. de Boer
    Adrian F. Hernandez
    Carolyn S. P. Lam
    Silvio E. Inzucchi
    Felipe A. Martinez
    Mikhail N. Kosiborod
    David DeMets
    Eileen O’Meara
    Shelley Zieroth
    Josep Comin-Colet
    Jaroslaw Drozdz
    Chern-En Chiang
    Masafumi Kitakaze
    Magnus Petersson
    Daniel Lindholm
    Anna Maria Langkilde
    John J. V. McMurray
    Scott D. Solomon
    Nature Medicine, 2022, 28 : 2504 - 2511
  • [6] Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
    Vardeny, Orly
    Fang, James C.
    Desai, Akshay S.
    Jhund, Pardeep S.
    Claggett, Brian
    Vaduganathan, Muthiah
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Lam, Carolyn S. P.
    Inzucchi, Silvio E.
    Martinez, Felipe A.
    Kosiborod, Mikhail N.
    DeMets, David
    O'Meara, Eileen
    Zieroth, Shelley
    Comin-Colet, Josep
    Drozdz, Jaroslaw
    Chiang, Chern-En
    Kitakaze, Masafumi
    Petersson, Magnus
    Lindholm, Daniel
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    NATURE MEDICINE, 2022, 28 (12) : 2504 - +
  • [7] Response by Denfeld et al to Letter Regarding Article, "Characterizing Sex Differences in Physical Frailty Phenotypes in Heart Failure"
    Denfeld, Quin E.
    Winters-Stone, Kerri
    Camacho, S. Albert
    Lee, Christopher S.
    CIRCULATION-HEART FAILURE, 2022, 15 (03)
  • [8] Response by Kato et al to Letter Regarding Article, "Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus"
    Kato, Eri T.
    Sabatine, Marc S.
    Wiviott, Stephen D.
    CIRCULATION, 2019, 140 (18) : E740 - E741
  • [9] Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
    Orly Vardeny
    James C. Fang
    Akshay S. Desai
    Pardeep S. Jhund
    Brian Claggett
    Muthiah Vaduganathan
    Rudolf A. de Boer
    Adrian F. Hernandez
    Carolyn S. P. Lam
    Silvio E. Inzucchi
    Felipe A. Martinez
    Mikhail N. Kosiborod
    David DeMets
    Eileen O’Meara
    Shelley Zieroth
    Josep Comin-Colet
    Jaroslaw Drozdz
    Chern-En Chiang
    Masafumi Kitakaze
    Magnus Petersson
    Daniel Lindholm
    Anna Maria Langkilde
    John J. V. McMurray
    Scott D. Solomon
    Nature Medicine, 2023, 29 : 3269 - 3269
  • [10] Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial
    Butt, Jawad H.
    Docherty, Kieran F.
    Petrie, Mark C.
    Schou, Morten
    Kosiborod, Mikhail N.
    O'Meara, Eileen
    Katova, Tzvetana
    Ljungman, Charlotta E. A.
    Diez, Mirta
    Ogunniyi, Modele O.
    Langkilde, Anna Maria
    Sjostrand, Mikaela
    Lindholm, Daniel
    Bengtsson, Olof
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Solomon, Scott D.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Kober, Lars
    JAMA CARDIOLOGY, 2021, 6 (06) : 678 - 689
12345